These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 20196437)

  • 21. Pandemic (H1N1) 2009 influenza.
    Polkinghorne B; Ward K; Totaro R
    N S W Public Health Bull; 2010; 21(1-2):41-2. PubMed ID: 21367344
    [No Abstract]   [Full Text] [Related]  

  • 22. Safety review: squalene and thimerosal in vaccines.
    Montana M; Verhaeghe P; Ducros C; Terme T; Vanelle P; Rathelot P
    Therapie; 2010; 65(6):533-41. PubMed ID: 21176760
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Immunogenicity and tolerability of a virosome influenza vaccine compared to split influenza vaccine in patients with sickle cell anemia.
    Souza AR; Braga JA; de Paiva TM; Loggetto SR; Azevedo RS; Weckx LY
    Vaccine; 2010 Jan; 28(4):1117-20. PubMed ID: 20116631
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Comparison of the efficacy and safety of live attenuated cold-adapted influenza vaccine, trivalent, with trivalent inactivated influenza virus vaccine in children and adolescents with asthma.
    Fleming DM; Crovari P; Wahn U; Klemola T; Schlesinger Y; Langussis A; Øymar K; Garcia ML; Krygier A; Costa H; Heininger U; Pregaldien JL; Cheng SM; Skinner J; Razmpour A; Saville M; Gruber WC; Forrest B;
    Pediatr Infect Dis J; 2006 Oct; 25(10):860-9. PubMed ID: 17006278
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Monovalent influenza A(H1N1) vaccine, 1986-1987.
    Centers for Disease Control (CDC)
    MMWR Morb Mortal Wkly Rep; 1986 Aug; 35(32):517-21. PubMed ID: 3090424
    [No Abstract]   [Full Text] [Related]  

  • 26. Monovalent influenza A(H1N1) vaccine, 1986-1987. Recommendations of the Immunization Practices Advisory Committee. Centers for Disease Control, Department of Health and Human Services.
    Ann Intern Med; 1986 Nov; 105(5):737-9. PubMed ID: 3021040
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Influenza vaccine 2008-2009.
    Med Lett Drugs Ther; 2008 Oct; 50(1296):77-9. PubMed ID: 18833032
    [TBL] [Abstract][Full Text] [Related]  

  • 28. H1N1 vaccine safety monitoring: beyond background rates.
    Destefano F; Tokars J
    Lancet; 2010 Apr; 375(9721):1146-7. PubMed ID: 19880171
    [No Abstract]   [Full Text] [Related]  

  • 29. What you need to know about the H1N1 vaccine.
    Park A
    Time; 2009 Oct; 174(13):40-1. PubMed ID: 19873689
    [No Abstract]   [Full Text] [Related]  

  • 30. Immunogenicity and tolerability of inactivated flu vaccine in high risk and healthy children.
    Avila Aguero ML; Soriano-Fallas A; Umaña-Sauma MA; Ulloa-Gutierrez R; Arnoux S
    Medicina (B Aires); 2007; 67(4):351-9. PubMed ID: 17891930
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Animal models for the preclinical evaluation of candidate influenza vaccines.
    Bodewes R; Rimmelzwaan GF; Osterhaus AD
    Expert Rev Vaccines; 2010 Jan; 9(1):59-72. PubMed ID: 20021306
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [New influenza. What you should know about vaccination (interview by Dr. Judith Neumaier)].
    Haas W
    MMW Fortschr Med; 2009 Aug; 151(34-35):12. PubMed ID: 19771780
    [No Abstract]   [Full Text] [Related]  

  • 33. Rapid decline of influenza vaccine-induced antibody in the elderly: is it real, or is it relevant?
    Skowronski DM; Tweed SA; De Serres G
    J Infect Dis; 2008 Feb; 197(4):490-502. PubMed ID: 18275271
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [The influenza season 2004/'05 in the Netherlands with the largest epidemic of the last 5 years caused by the virus variant A/California and the composition of the vaccine for the season 2005/'06].
    de Jong JC; Rimmelzwaan GF; Bartelds AI; Meijer A; Fouchier RA; Osterhaus AD
    Ned Tijdschr Geneeskd; 2005 Oct; 149(42):2355-61. PubMed ID: 16261717
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Policy statement--recommendations for the prevention and treatment of influenza in children, 2009 -2010.
    Committee on Infectious Diseases
    Pediatrics; 2009 Oct; 124(4):1216-26. PubMed ID: 19736264
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [The 2005-2006 influenza season in the Netherlands and the vaccine composition for the 2006-2007 season].
    Rimmelzwaan GF; de Jong JC; Donker GA; Meijer A; Fouchier RA; Osterhaus AD
    Ned Tijdschr Geneeskd; 2006 Oct; 150(40):2209-14. PubMed ID: 17061434
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Guillain-Barré syndrome in children aged <15 years in Latin America and the Caribbean: baseline rates in the context of the influenza A (H1N1) pandemic.
    Landaverde JM; Danovaro-Holliday MC; Trumbo SP; Pacis-Tirso CL; Ruiz-Matus C
    J Infect Dis; 2010 Mar; 201(5):746-50. PubMed ID: 20102270
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Superior relative efficacy of live attenuated influenza vaccine compared with inactivated influenza vaccine in young children with recurrent respiratory tract infections.
    Ashkenazi S; Vertruyen A; Arístegui J; Esposito S; McKeith DD; Klemola T; Biolek J; Kühr J; Bujnowski T; Desgrandchamps D; Cheng SM; Skinner J; Gruber WC; Forrest BD;
    Pediatr Infect Dis J; 2006 Oct; 25(10):870-9. PubMed ID: 17006279
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Safety of influenza vaccination: Risk-benefit evaluation.
    Wiwanitkit V
    Muscle Nerve; 2010 Aug; 42(2):296; author reply 296. PubMed ID: 20544931
    [No Abstract]   [Full Text] [Related]  

  • 40. The new H1N1 and HPV vaccines and old fears.
    Balofsky A; Agmon-Levin N; Shoenfeld Y
    Curr Opin Rheumatol; 2010 Jul; 22(4):431-6. PubMed ID: 20485175
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.